![C. Chandran](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
C. Chandran
Directeur/Membre du Conseil chez
STATERA BIOPHARMA, INC.
Profil
C.
Satish Chandran is the founder of Nucleonics, Inc., founded in 2001.
Dr. Chandran was the founder of Somahlution LLC, founded in 2010, and served as Chief Executive Officer & Director from 2010 to 2020.
Current jobs include President & Chief Executive Officer at Lays Sciences, Independent Director at Ocugen, Inc. starting in 2025, and Director at Statera Biopharma, Inc. starting in 2022.
Former jobs include Chief Executive Officer at Akshaya Bio, Inc. from 2021 to 2023, Independent Director at Statera Biopharma, Inc. from 2022 to 2023, Associate Professor at Thomas Jefferson University, Professor at North Dakota State University from 2010 to 2012, and President, Chief Operating & Technology Officer at Marizyme, Inc. from 2020 to 2021.
Education includes undergraduate studies at the University of Mumbai, graduate studies at the University of Baroda, and a doctorate from Memorial University of Newfoundland.
Postes actifs de C. Chandran
| Sociétés | Poste | Début |
|---|---|---|
| STATERA BIOPHARMA, INC. | Directeur/Membre du Conseil | 01/02/2022 |
| OCUGEN, INC. | Directeur/Membre du Conseil | 05/06/2025 |
Lays Sciences | Directeur Général | - |
Anciens postes connus de C. Chandran
| Sociétés | Poste | Fin |
|---|---|---|
| STATERA BIOPHARMA, INC. | Directeur/Membre du Conseil | 12/01/2023 |
Akshaya Bio, Inc.
 Akshaya Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for infectious diseases and cancer | Directeur Général | 01/01/2023 |
| MARIZYME, INC. | President | 02/04/2021 |
Somahlution LLC
 Somahlution LLC Medical DistributorsDistribution Services Engages in developing products to prevent ischemic injury to organs and tissues and its products | Fondateur | 01/08/2020 |
North Dakota State University
 North Dakota State University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2012 |
Formation de C. Chandran
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
57
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Thomas Jefferson University
 Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Nucleonics, Inc.
 Nucleonics, Inc. Pharmaceuticals: MajorHealth Technology Develops RNA interference-based therapeutics | Health Technology |
Memorial University of Newfoundland
 Memorial University of Newfoundland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
North Dakota State University
North Dakota State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Mumbai
 University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Baroda
 University of Baroda Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Marizyme, Inc.
 Marizyme, Inc. BiotechnologyHealth Technology Engages in development and commercialization of medical products and technologies | Health Technology |
Somahlution LLC
Somahlution LLC Medical DistributorsDistribution Services Engages in developing products to prevent ischemic injury to organs and tissues and its products | Distribution Services |
Akshaya Bio, Inc.
Akshaya Bio, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for infectious diseases and cancer | Health Technology |
Ocugen, Inc.
 Ocugen, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapy products | Health Technology |
Statera Biopharma, Inc.
 Statera Biopharma, Inc. BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops novel small molecule immunotherapies | Health Technology |
Lays Sciences |
